James talks to Professor Steve Chadban about acute kidney injury (AKI). AKI develops in 5 - 20% of hospitalised patients and is a significant contributor to morbidity and mortality in the critically ill. Acute kidney injury ranges from mild to severe disease requiring renal replacement therapy. Here, we'll deconstruct the causes of AKI to outline a helpful and systemic approach for junior doctors.
Summary Writer: Amanda White
Editor: James Edwards
Interviewee: Steve Chadban
About Steve Chadban
Steve Chadban studied Medicine at the University of Newcastle, Australia, where he received the University Medal in Medicine. He undertook physician training in Newcastle, before specialising in Nephrology, completing a PhD in macrophage biology at Monash University, then a post-doctoral study period in immunology at the University of Cambridge, UK.
Steve returned to Monash University to run the Transplantation Program from 1999–2002 before moving to Royal Prince Alfred Hospital, where he is a full-time staff Nephrologist, Director of Kidney Transplantation, Professor of Medicine (Nephrology) at The University of Sydney and researcher in basic and clinical sciences. Steve is the President-elect of the TSANZ, Executive member of ANZDATA and a Lead Investigator in the AusDiab Kidney Study. He has spoken at numerous National and International meetings and produced over 170 papers published in leading international journals including The New England Journal of Medicine, JAMA and The Journal of Clinical Investigation.
Steve’s research interests include the molecular mechanisms of transplant rejection, with a focus on macrophages and innate immunity, clinical transplantation, diabetes and outcomes in CKD and transplantation.